DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS

NEWS RELEASE

Released: April 5, 2012

Defense Health Program
Department of Defense Lung Cancer Research Program
Funding Opportunities for Fiscal Year 2012

The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $5.12 million (M) to the Department of Defense Autism Research Program (ARP). The vision of the ARP is to improve the lives of individuals with autism spectrum disorders (ASD) now. This program is administered by the US Army Medical Research and Materiel Command through the Office of the Congressionally Directed Medical Research Programs (CDMRP).

The ARP is providing the information in this pre-announcement to allow investigators time to plan and develop applications. FY12 ARP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on Grants.gov in May 2012. Pre-application and application deadlines will be available when the Program Announcements are released. This pre-announcement should not be construed as an obligation by the government.

Award Mechanism Eligibility Key Mechanism Elements Funding
Concept Award Investigators at all academic levels (or equivalent)
  • Supports highly innovative, untested, potentially groundbreaking concepts in lung cancer
  • Emphasis is on innovation
  • Presentation of preliminary data is not consistent with the intent of the Concept Award mechanism and is discouraged
  • Human subject studies are permitted provided the studies are exempt or eligible for expedited review
  • Maximum funding of $100K for direct costs (plus indirect costs)
  • Maximum period of performance is 1 year
Idea Development Award Independent investigators at or above the level of an Assistant Professor (or equivalent); must be within 10 years of first faculty appointment
  • Supports new ideas that are in the early stages of development which represent innovative, high-risk/high-gain approaches to lung cancer research
  • Emphasis is on Innovation and Impact
  • Preliminary data required, but may be from outside of lung cancer
  • Clinical trials are not allowed
  • Maximum funding of $350K for direct costs (plus indirect costs)
  • Maximum period of performance is 2 years
Translational Research Partnership Award Investigators at or above the level of Assistant Professor (or equivalent)
  • Supports partnerships between clinicians and laboratory scientists that accelerate ideas in lung cancer into clinical applications
  • Preliminary data required, but may be from outside of lung cancer
  • Clinical trials are not allowed
  • Non-Traditional Partnerships are encouraged
  • Optional Nested Clinical Fellow or Resident Traineeship
  • Maximum combined funding of $900K for direct costs (plus indirect costs)
  • Maximum period of performance is 3 years
  • Nested traineeships: Additional maximum of $75K in direct and indirect costs over a one-year period of performance

All applications must conform to the final Program Announcements and application instructions that will be available for electronic downloading from the Grants.gov website. The applications package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline. Applications must be submitted through the federal government's single-entry portal, Grants.gov. Submission deadlines are not available until the Program Announcements are released. Requests for email notification of the Program Announcements release may be sent to help@cdmrp.org. Email notifications of funding opportunities are sent as a courtesy and should not be used as a sole source of notification; applicants should monitor Grants.gov for official postings of funding opportunities.

For more information about the LCRP or other CDMRP-sponsored programs, please visit the CDMRP website (http://cdmrp.army.mil).

Point of Contact:

CDMRP Public Affairs
301-619-9783
CDMRP.PublicAffairs@amedd.army.mil